Pharmadrug Inc.

CNSX: BUZZ


Canadian symbol: BUZZ.CN
US symbol: LMLLF

Currency in CAD

Valuation Measures

Market Cap (intraday) 53.33M
Enterprise Value 310.3M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)5.46
Price/Book (mrq)1.11
Enterprise Value/Revenue 316.87
Enterprise Value/EBITDA 6-2.40

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-60.00%
S&P500 52-Week Change 36.72%
52 Week High 30.1500
52 Week Low 30.0100
50-Day Moving Average 30.0703
200-Day Moving Average 30.0365

Share Statistics

Avg Vol (3 month) 32.75M
Avg Vol (10 day) 32.39M
Shares Outstanding 583.3M
Float 125.43M
% Held by Insiders 132.04%
% Held by Institutions 10.00%
Shares Short (Jun. 14, 2020) 48.1M
Short Ratio (Jun. 14, 2020) 41.89
Short % of Float (Jun. 14, 2020) 4N/A
Short % of Shares Outstanding (Jun. 14, 2020) 49.73%
Shares Short (prior month May 14, 2020) 4293.57k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Aug. 01, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Dec. 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-825.60%

Management Effectiveness

Return on Assets (ttm)-55.08%
Return on Equity (ttm)-329.61%

Income Statement

Revenue (ttm)610.58k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)253.25k
EBITDA -4.29M
Net Income Avi to Common (ttm)-6.29M
Diluted EPS (ttm)-0.0900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)73.68k
Total Cash Per Share (mrq)0
Total Debt (mrq)3.12M
Total Debt/Equity (mrq)70.03
Current Ratio (mrq)0.08
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)-2.34M
Levered Free Cash Flow (ttm)-1.23M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
BUZZ.CN
Pharmadrug
7 months ago
BUZZ.CN
Pharmadrug
7 months ago
BUZZ.CN
Pharmadrug
7 months ago
BUZZ.CN
Pharmadrug
7 months ago
BUZZ.CN
Pharmadrug
8 months ago
BUZZ.CN
Pharmadrug
8 months ago
BUZZ.CN
Pharmadrug
9 months ago
BUZZ.CN
Pharmadrug
9 months ago
BUZZ.CN
Pharmadrug
10 months ago
BUZZ.CN
Pharmadrug
10 months ago
BUZZ.CN
Pharmadrug
11 months ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago
BUZZ.CN
Pharmadrug
1 year ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
32.04%% of Shares Held by All Insider
0.00%% of Shares Held by Institutions
0.00%% of Float Held by Institutions
0Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Pharmadrug Inc.


Pharmadrug Inc. Announces Postponement of Executive Compensation Disclosure

Pharmadrug Inc. Announces Postponement of Executive Compensation Disclosure

Toronto, Ontario--(Newsfile Corp. - June 29, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug") announced that it will be relying on the temporary blanket relief provided by the Canadian Securities Administrators to postpone filing of its executive compensation disclosure required under applicable securities laws until such t... Read More...
Top Canadian Entreprenuer Michael Forbes Joins the Board of Directors of PharmaDrug Inc.

Top Canadian Entreprenuer Michael Forbes Joins the Board of Directors of PharmaDrug Inc.

Toronto, Ontario--(Newsfile Corp. - June 19, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug") is pleased to announce that Michael Forbes will be joining the board effective immediately.Over the course of 16 years, Michael has created and operated a chain of pharmacies throughout BC and Alberta. Michael's innovative nature l... Read More...
Pharmadrug Inc. Completes Acquisition of Super Smart with a New Added Focus on the Psychedelic Market

Pharmadrug Inc. Completes Acquisition of Super Smart with a New Added Focus on the Psychedelic Market

Toronto, Ontario--(Newsfile Corp. - June 15, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("Pharmadrug") is pleased to announce that it has completed its previously announced (see press release dated May 25, 2020) acquisition of all of the issued and outstanding shares of privately-held Interrobang Ltd. (doing business as Super Smart)... Read More...
Pharmadrug Inc. Enters Definitive Agreement to Acquire Super Smart Paving Its Entry into the Psychedelic Market

Pharmadrug Inc. Enters Definitive Agreement to Acquire Super Smart Paving Its Entry into the Psychedelic Market

Toronto, Ontario--(Newsfile Corp. - May 25, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("Pharmadrug") is pleased to announce that it has entered into a definitive agreement (the "Acquisition Agreement") pursuant to which Pharmadrug will acquire all of the issued and outstanding shares of privately-held Interrobang Ltd. (doing busine... Read More...
Pharmadrug Inc. Plans to Enter the Psychedelic Space with An LOI To Acquire Super Smart and Provides Business Update

Pharmadrug Inc. Plans to Enter the Psychedelic Space with An LOI To Acquire Super Smart and Provides Business Update

Toronto, Ontario--(Newsfile Corp. - May 20, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("Pharmadrug") is pleased to announce that it has entered into a non-binding letter of intent (the "Letter of Intent") dated May 20, 2020 with Interrobang Ltd. doing business as Super Smart (herein referred to as "Super Smart") which outlines the ... Read More...
Pharmadrug Inc. Provides Update on COVID-19 and Announces Request for Extension of Filing Financial Statements as Well as Positive Business and Corporate Updates

Pharmadrug Inc. Provides Update on COVID-19 and Announces Request for Extension of Filing Financial Statements as Well as Positive Business and Corporate Updates

Toronto, Ontario--(Newsfile Corp. - April 24, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the "Company") is providing an update on COVID-19 matters and an update on the status of filing its financial statements and accompanying management's discussion and analysis, and related CEO and CFO certifications for the financial year ended ... Read More...
Pharmadrug Inc. Enters Secured Loan Agreement and LOI for Possible Business Combination

Pharmadrug Inc. Enters Secured Loan Agreement and LOI for Possible Business Combination

Toronto, Ontario--(Newsfile Corp. - February 7, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the "Company") is pleased to announce that it has secured a private loan (the "Loan") of $250,000 from an arm's length third party lender (the "Lender"). The Loan carries an interest rate of 9% per annum accruing every 90 days, payable on mat... Read More...
Pharmadrug Signs Major Canadian Supply Agreement with Canada House Wellness for German Distribution as German Governing Party Moves Closer to Recreational Cannabis Legislation

Pharmadrug Signs Major Canadian Supply Agreement with Canada House Wellness for German Distribution as German Governing Party Moves Closer to Recreational Cannabis Legislation

Toronto, Ontario--(Newsfile Corp. - October 31, 2019) - Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the "Company" or "Pharmadrug") is pleased to announce a multi-year supply agreement (the "Supply Agreement") between 80% owned subsidiary Pharmadrug Production GmbH and Canada House Wellness Group Inc. (CSE: CHV) (the "Grower" or "Canada Hous... Read More...
Aura Health Announces Name Change to Pharmadrug to Reflect Focus on Pharmaceutical Medicine

Aura Health Announces Name Change to Pharmadrug to Reflect Focus on Pharmaceutical Medicine

Toronto, Ontario--(Newsfile Corp. - October 21, 2019) - Aura Health Inc. ("Aura") (CSE:BUZZ) (OTC: LMLLF) is pleased to announce that it has completed its name change from Aura Health Inc. to Pharmadrug Inc. ("Pharmadrug" or the "Company") (the "Name Change"). Aura's shareholders approved the name change at the annual and special meeting ... Read More...
Aura's Pharmadrug Signs Major Supply Agreement Setting Stage for Brand Launch & Expanded Distribution

Aura’s Pharmadrug Signs Major Supply Agreement Setting Stage for Brand Launch & Expanded Distribution

Toronto, Ontario--(Newsfile Corp. - September 19, 2019) - Aura Health Inc. (CSE:BUZZ) (OTC:LMLLF) (the "Company" or "Aura") is pleased to announce a multi-year supply agreement (the "Supply Agreement") between 80% owned subsidiary Pharmadrug Production GmbH ("Pharmadrug") and Israel-based My Green Fields Ltd. ("My Green Fields" or the "Gr... Read More...
Aura Signs Master Grower for Israel

Aura Signs Master Grower for Israel

TORONTO, June 14, 2019 -- Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) is pleased to announce the signing of master grower, Adrian Richelmi, to build and operate HolyCanna’s 60,000 square foot greenhouse facilty in Israel. Aura is a debt holder of HolyCanna that converts into 54% equity (see press release dated November 23, ... Read More...
Aura Provides Clarification on Pharmadrug's Supply Agreements and Relationship With Bedrocan

Aura Provides Clarification on Pharmadrug’s Supply Agreements and Relationship With Bedrocan

TORONTO, June 07, 2019 -- Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) wishes to clarify the nature of the supply arrangement by which Pharmadrug Production GmbH (“Pharmadrug”) is importing and distributing cannabis to pharmacies in Germany.In a press release dated June 5th, 2019, the Company announced that Pharmadrug has ordered... Read More...
Aura Initiates Investor Relations Strategy

Aura Initiates Investor Relations Strategy

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.TORONTO, May 24, 2019 -- Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) is pleased to announce that it has engaged two firm... Read More...
Aura Announces Strategic Entry Into the European Market With the Closing of the Acquisition of Pharmadrug

Aura Announces Strategic Entry Into the European Market With the Closing of the Acquisition of Pharmadrug

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.TORONTO, May 17, 2019 -- Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) is pleased to announce that it has closed the previ... Read More...
Aura Announces Supply Agreement With FSD Pharma & Conditions Met to Close German Acquisition

Aura Announces Supply Agreement With FSD Pharma & Conditions Met to Close German Acquisition

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.TORONTO, May 08, 2019 -- Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) is pleased to announce a multi-year supply agreemen... Read More...
Aura Health Announces $5.82 Million Closing of the Second Tranche of Its Subscription Receipt Offering and Share Exchange Transaction

Aura Health Announces $5.82 Million Closing of the Second Tranche of Its Subscription Receipt Offering and Share Exchange Transaction

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.TORONTO, April 17, 2019 -- Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) is pleased to announce that it has closed the second tranche of its p... Read More...
Aura Health Announces Pricing of Previously Announced $5.0 Million Brokered Subscription Receipt Financing

Aura Health Announces Pricing of Previously Announced $5.0 Million Brokered Subscription Receipt Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.TORONTO, Feb. 08, 2019 -- Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) is pleased to announce the price and terms of its brokered private pla... Read More...
Israel Passes Cannabis Export Law, Paving Path for Aura's European Distribution

Israel Passes Cannabis Export Law, Paving Path for Aura’s European Distribution

TORONTO, Jan. 28, 2019 -- Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) is pleased with the final approval of Israel’s export law for medical cannabis.On Sunday, January 27, the Israeli government announced the new law, approving the export of Israeli-grown cannabis to the global market. The law makes Israel the third country in t... Read More...
Aura Announces Binding LOI to Acquire Licenced Medical Cannabis Distributor in Germany

Aura Announces Binding LOI to Acquire Licenced Medical Cannabis Distributor in Germany

TORONTO, Jan. 25, 2019 -- Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) is pleased to announce that the Company has entered into a binding letter of intent (the “LOI”) to acquire 80% of Pharmadrug Production GmbH (“Pharmadrug”) for EUR5,000,000.Pharmadrug is a cash flow positive German pharmaceutical distribution company with over... Read More...
Coming Soon.
SymbolExchangePriceChangeAs of
BUZZ.CD
Canadian Securities Exchange - CSE Listed
Canadian Securities Exchange - CSE Listed0.04CAD--
BUZZ.CCP
Canadian Composite Quote/Trade
Canadian Composite Quote/Trade0.04CAD-20.00%
LMLLF.PK
OTC MARKETS GROUP L1 AND L2
OTC MARKETS GROUP L1 AND L20.04USD+3.55%
LMLLF.PQ
OTC MARKETS GROUP L1 AND L2
OTC MARKETS GROUP L1 AND L20.04USD-53.33%
BUZZ.CXC
Nasdaq CXC
Nasdaq CXC0.05CAD-10.00%
BUZZ.OMG
Omega - Candian ATS
Omega - Candian ATS0.04CAD-11.11%
BUZZ.CXX
Nasdaq CX2
Nasdaq CX20.04CAD-20.00%

Delayed data (1h)


Share this page